well I have had a conservative value of between 3.00-5.00 a share just on the legal deal alone, that valuation does not include any sales
I am not disputing your figures
my understanding is currently bta reliant on gsk to deliver the sales and revenue there is only royalties of 7%
however hopefully bta get a different deal on the new drugs as 7% seems pitiful compared to the expertise in finding the solution
they should get a better deal to share in the profits
cheers
- Forums
- ASX - By Stock
- BTA
- medium-term valuation
medium-term valuation, page-5
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online